Identification of SLIT3 mutation as a response biomarker for immune checkpoint inhibitor therapy in non-small cell lung cancer. - Wang W; Wang J; Ge T; Wang X; Yang M; Zhu J; Ji C; Shu P (Discover oncology, 2026)